Crossmark

Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries

Published Online: 2023-06-23

Published Print: 2023-09

Authors

Funding, Eva

Lowe, Gillian https://orcid.org/0000-0003-2527-9557
Poulsen, Lone H.

Shapiro, Susan https://orcid.org/0000-0003-0402-0802
Oldenburg, Johannes

Eriksson, Daniel https://orcid.org/0000-0001-7699-242X
Falk, Aletta

Rich, Carly https://orcid.org/0000-0003-4717-5855
Funding

Funding for this research was provided by:

Swedish Orphan Biovitrum
License Information

Text and Data Mining valid from 2023-06-23

Version of Record valid from 2023-06-23
More Information

Article History

Received: 14 February 2023

Accepted: 18 May 2023

First Online: 23 June 2023

Document is current